Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-11-24Clinical Trial Update: Efficacy and Safety of JMT101 Combined With Osimertinib in Patients With Non-Small Cell Lung Cancer [Phase 2]
Phase 2 trial update assessing efficacy and safety of JMT101 plus osimertinib in non-small cell lung cancer with EGFR Exon 20 insertion muta…
-
CLINICAL_TRIALS trial_result · 2021-11-24Clinical Trial Update: KN046 in Subjects With Advanced Squamous Non-small Cell Lung Cancer [Phase 3]
Phase 3 trial update for KN046 in subjects with squamous non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2021-11-23Clinical Trial Update: Phase 2 Study of Study of Tesevatinib in Subjects With NSCLC and Brain or Leptomeningeal Metastases [Phase 2]
Phase 2 study of tesevatinib in subjects with non-small cell lung cancer and brain or leptomeningeal metastases has completed; results poste…
-
CLINICAL_TRIALS trial_result · 2021-11-22Clinical Trial Update: Tislelizumab Combined With Chemotherapy With or Without Bevacizumab in TKI-Resistant EGFR-Mutated Non-squamous NSCLC [Phase 2]
Phase 2 trial update investigating tislelizumab combined with chemotherapy with or without bevacizumab in EGFR-mutated, TKI-resistant non-sq…
-
CLINICAL_TRIALS trial_result · 2021-11-18Clinical Trial Update: Neo-adjuvant Trial With AZD9291 in EGFRm+ Stage IIIA/B NSCLC [Phase 2]
A phase 2 clinical trial update on a neo-adjuvant treatment with AZD9291 (osimertinib) for EGFR-mutant stage IIIA/B non-small cell lung canc…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-11-12Clinical Trial Update: MnSOD (Esophageal Protectant) to Prevent Esophagitis During Radiation/Chemotherapy Treatment for Non-Small Cell Lung Cancer (NSCLC) [Phase 1, Phase 2]
Phase 1/2 trial investigating MnSOD as an esophageal protectant to reduce esophagitis during radiation/chemotherapy for non-small cell lung …
-
CLINICAL_TRIALS trial_result · 2021-11-11Clinical Trial Update: Safety and Efficacy of Chimeric Antigen Receptor T Lymphocytes for Patients With Intermediate and Advanced Tumors [Phase 1, Phase 2]
Clinical trial update on CAR-T therapy for intermediate and advanced tumors, including melanoma and non-small cell lung cancer, across Phase…
-
CLINICAL_TRIALS trial_result · 2021-11-08Clinical Trial Update: A Study of Sintilimab Compared With Docetaxel or Pemetrexed as Second-line Treatment for Patients With Stage IV Nonsquamous Non-small Cell Lung Cancer After Failure With Platinum-Containing Chemotherapy [Phase 2]
Phase 2 trial evaluating sintilimab vs docetaxel or pemetrexed as second-line therapy for stage IV nonsquamous non-small cell lung cancer af…
-
CLINICAL_TRIALS trial_result · 2021-11-04Clinical Trial Update: A Trial of SHR-1316/Placebo in Combination With Chemotherapy in Patients With Resectable NSCLC [Phase 3]
Phase 3 trial update for SHR-1316 in combination with chemotherapy versus placebo in resectable non-small cell lung cancer is currently recr…
-
CLINICAL_TRIALS trial_result · 2021-10-29Clinical Trial Update: Jinfukang Oral Liquid Combined With Chemotherapy for Treating Driver Gene-negative Advanced NSCLC [Phase 4]
Phase 4 trial update on Jinfukang oral liquid combined with chemotherapy for driver gene-negative advanced non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2021-10-26Clinical Trial Update: A Study of Lorlatinib in ALK Inhibitor-Treated ALK-Positive NSCLC in China [Phase 2]
Phase 2 study evaluating lorlatinib in ALK inhibitor-treated ALK-positive non-small cell lung cancer in China has completed, and results wer…
-
CLINICAL_TRIALS trial_result · 2021-10-25Clinical Trial Update: Study of Capmatinib and Spartalizumab Combination Therapy vs Docetaxel in Non-small Cell Lung Cancer [Phase 2]
Phase 2 trial comparing capmatinib plus spartalizumab versus docetaxel in non-small cell lung cancer has completed with results posted in 20…
-
CLINICAL_TRIALS trial_result · 2021-10-25Clinical Trial Update: Real World Treatment Study of AZD9291 for Advanced/Metastatic EGFR T790M Mutation NSCLC [Phase 3]
A phase 3 real-world trial assessing AZD9291 (osimertinib) for advanced/metastatic EGFR T790M mutation non-small cell lung cancer has comple…
-
CLINICAL_TRIALS trial_result · 2021-10-25Clinical Trial Update: NIvolumab COmbination With Standard First-line Chemotherapy and Radiotherapy in Locally Advanced Stage IIIA/B Non-Small Cell Lung Carcinoma [Phase 2]
A Phase 2 trial evaluating nivolumab in combination with standard first-line chemotherapy and radiotherapy for locally advanced stage IIIA/B…
-
CLINICAL_TRIALS trial_result · 2021-10-20Clinical Trial Update: A Study of Carboplatin-Paclitaxel/Nab-Paclitaxel Chemotherapy With or Without Pembrolizumab (MK-3475) in Adults With First Line Metastatic Squamous Non-small Cell Lung Cancer (MK-3475-407/KEYNOTE-407)-China Extension Study [Phase 3]
Phase 3 China extension study evaluating pembrolizumab added to carboplatin-paclitaxel or nab-paclitaxel as first-line therapy for metastati…
-
CLINICAL_TRIALS trial_result · 2021-10-14Clinical Trial Update: A Study Of Oral PF-02341066, A C-Met/Hepatocyte Growth Factor Tyrosine Kinase Inhibitor, In Patients With Advanced Cancer [Phase 1]
Phase 1 study of oral PF-02341066 (crizotinib) as a tyrosine kinase inhibitor targeting c-Met/HGF pathway in advanced cancers; study complet…
-
CLINICAL_TRIALS trial_result · 2021-10-12Clinical Trial Update: A Study of MM-121 in Combination With Chemotherapy Versus Chemotherapy Alone in Heregulin Positive NSCLC [Phase 2]
Phase 2 trial of MM-121 with chemotherapy versus chemotherapy alone in heregulin-positive non-small cell lung cancer has been terminated; re…
-
CLINICAL_TRIALS trial_result · 2021-10-12Clinical Trial Update: Feasibility Study of Enhanced MRI for Early Stage Non Small Cell Lung Cancer (NSCLC) [NA]
Feasibility study for enhanced MRI in early-stage non-small cell lung cancer was terminated; results posted.
-
CLINICAL_TRIALS trial_result · 2021-10-08Clinical Trial Update: NY-ESO-1 Plasmid DNA (pPJV7611) Cancer Vaccine [Phase 1]
Phase 1 clinical trial update for NY-ESO-1 plasmid DNA cancer vaccine pPJV7611 in multiple cancers with completed status and posted results.
-
CLINICAL_TRIALS trial_result · 2021-10-07Clinical Trial Update: A Phase I Trial of Vandetanib (AZD6474) and Selumetinib (AZD6244) for Solid Tumours Including Non Small Cell Lung Cancer (VanSel-1) [Phase 1]
A Phase I trial evaluating vandetanib plus selumetinib for solid tumors including non-small cell lung cancer completed with results posted i…
-
CLINICAL_TRIALS trial_result · 2021-10-06Clinical Trial Update: Web-based Intervention for Lung Cancer Patients and Their Informal Caregivers [Phase 3]
Phase 3 clinical trial evaluating a web-based intervention for lung cancer patients and informal caregivers has completed.
-
CLINICAL_TRIALS trial_result · 2021-10-06Clinical Trial Update: Phase 1/2 Study of X-396, an Oral ALK Inhibitor, in Patients With ALK-positive Non-Small Cell Lung Cancer [Phase 1, Phase 2]
Phase 1/2 study of X-396 (an oral ALK inhibitor) in ALK-positive non-small cell lung cancer and other advanced solid tumors has completed.
-
CLINICAL_TRIALS trial_result · 2021-10-05Clinical Trial Update: Phase I/II NabPaclitaxel, Paclitaxel&Carboplatin w RTX Followed by Consolidation in Patients w Favorable Prognosis Inoperable Stage IIIA/B NSCLC [Phase 1, Phase 2]
Phase I/II trial evaluating Nab-Paclitaxel or Paclitaxel with Carboplatin and RTX followed by consolidation in favorable prognosis inoperabl…
-
CLINICAL_TRIALS trial_result · 2021-10-01Clinical Trial Update: A Study of BBI608 in Combination With Pemetrexed and Cisplatin in Adult Patients With Malignant Pleural Mesothelioma [Phase 1, Phase 2]
Phase 1/2 trial investigating BBI608 with pemetrexed and cisplatin in malignant pleural mesothelioma and non-small cell lung cancer has comp…
-
CLINICAL_TRIALS trial_result · 2021-09-29Clinical Trial Update: Phase I/II Study of PDR001 in Patients With Advanced Malignancies [Phase 1, Phase 2]
Phase I/II trial update for PDR001 in advanced malignancies completed with posted results.